Clinical factors influencing engraftment in patients with non-Hodgkin lymphoma following autologous stem cell transplant.

被引：0
|
作者：
Skelton, William Paul
Lutfi, Forat
Wang, Yu
Rosenau, Emma
Murthy, Hemant S.
Brown, Randy
Wingard, John R.
Norkin, Maxim
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Florida, Dept Biostatist, Gainesville, FL USA
[3] Univ Florida Hlth, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e19504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19504
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Non-Hodgkin Lymphoma in a Child With Neuroblastoma Preceding Autologous Stem Cell Transplant
    Blatt, Julie
    LaQuaglia, Michael
    Hunt, John P.
    Morris, David E.
    Kasow, Kimberly A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (03): : 213 - 215
  • [2] RITUXIMAB AND SARGRAMOSTIM IMMUNOTHERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA
    Scigliano, E.
    Grosskreutz, C. L.
    Osman, K.
    Malone, A.
    Nieto, J.
    Isola, L. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S208 - S209
  • [3] Effects of rituximab on stem cell mobilisation and engraftment in non-Hodgkin lymphoma patients
    Gaudio, F
    Pavone, V
    Guarini, A
    Perrone, T
    Curci, P
    Giordano, A
    De Francesco, R
    Liso, V
    BONE MARROW TRANSPLANTATION, 2006, 37 : S238 - S238
  • [4] Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    Prinz, E
    Mitterbauer, M
    Keil, F
    Kalhs, P
    Mitterbauer, G
    Höcker, P
    Jäger, U
    Chott, A
    Mannhalter, C
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S272 - S272
  • [5] PREDICTORS OF DELAYED PLATELET ENGRAFTMENT AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN LYMPHOMA
    Costa e Sousa, Rita
    Almeida, Catia
    Santos, Joao Gaiao
    Ferreira, Ricardo
    Urbano, Mafalda
    Afonso, Maria Carolina
    Gomes, Marilia
    Roque, Adriana
    Geraldes, Catarina
    BONE MARROW TRANSPLANTATION, 2024, 59 : 485 - 486
  • [6] Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma
    J Shortt
    A Spencer
    Bone Marrow Transplantation, 2006, 38 : 433 - 436
  • [7] Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma
    Shortt, J.
    Spencer, A.
    BONE MARROW TRANSPLANTATION, 2006, 38 (06) : 433 - 436
  • [8] Rituximab and Interleukin 2 for CD20 positive Non-Hodgkin's Lymphoma following autologous transplant.
    Holmberg, LA
    Maloney, DG
    Bensinger, WI
    BLOOD, 2002, 100 (11) : 646A - 647A
  • [9] Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients
    Varmavuo, Ville
    Rimpilainen, Johanna
    Kuitunen, Hanne
    Nihtinen, Anne
    Vasala, Kaija
    Mikkola, Maija
    Kutila, Anu
    Lehtonen, Paivi
    Kuittinen, Taru
    Mantymaa, Pentti
    Nousiainen, Tapio
    Kuittinen, Outi
    Jantunen, Esa
    TRANSFUSION, 2014, 54 (05) : 1243 - 1250
  • [10] Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients
    Varmavuo, V.
    Rimpilainen, J.
    Kuitunen, H.
    Nihtinen, A.
    Vasala, K.
    Mikkola, M.
    Kutila, A.
    Lehtonen, P.
    Kuittinen, T.
    Mantymaa, P.
    Nousiainen, T.
    Kuittinen, O.
    Jantunen, E.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S420 - S421
12345